Nurse Writing Services

NURS FPX 4030 Assessment 2 Determining the Credibility of Evidence and Resources

New Samples

Struggling With Your Assessments? Get Help From Our Tutors

    NURS FPX 4030 Assessment 2 Determining the Credibility of Evidence and Resources

    Student Name

    Capella University

    NURS FPX4030 Making Evidence-Based Decisions

    Prof. Name

    Date

    Type 2 Diabetes and Evidence-based Practice

    Managing Type 2 Diabetes (T2D) poses a substantial health challenge, necessitating an evidence-based approach to optimize disease management strategies. Uncontrolled diabetes can lead to severe health complications, diminished quality of life, and even mortality. Comprehensive evidence-based care approaches are outlined in guidelines provided by authoritative bodies such as the National Institute for Health and Care Excellence (NICE), the American Diabetes Association (ADA), and the World Health Organization (WHO). These guidelines encompass various aspects of care, including lifestyle changes, drug therapy, glycemic control, screening for complications, and managing comorbidities.

    Assessing the Credibility of Evidence and Resources

    Adopting evidence-based practice (EBP) in Type 2 diabetes management yields significant benefits by integrating the latest high-quality research, ensuring up-to-date and accurate management strategies. EBP supports individualized patient care by combining patient preferences, clinical expertise, and the best available evidence for optimal outcomes (ADA, 2021; NICE, 2021). Additionally, the World Health Organization (2021) emphasizes that evidence-based practices in healthcare settings promote standardized care, reduce variability, and enhance consistency in clinical decision-making. Supporting studies, such as the one by Wiviott et al. (2019), underscore the critical and beneficial nature of an evidence-based approach in managing various healthcare conditions, particularly Type 2 diabetes.

    Evaluating the Credibility of Resources

    The CRAAP criteria serve as a valuable tool for evaluating the trustworthiness of sources like journal articles and websites. This framework includes Currency, Relevance, Authority, Accuracy, and Purpose. A resource meeting these criteria is the World Health Organization’s (2021) “Global report on diabetes,” which stands out for its current and relevant information, authority as an international health organization, and its adherence to accuracy and purposeful guidance in line with WHO’s mission.

    Credibility and Relevance of Evidence and Resources

    Three specific resources related to Type 2 Diabetes were scrutinized for credibility and relevance. The American Diabetes Association (2021) “Standards of Medical Care in Diabetes Abridged for Primary Care Providers” is highly credible and relevant due to its extensive review process, incorporation of the latest research, and endorsement by a leading professional body. The National Institute for Health and Care Excellence (2021) “Type 2 diabetes in adults: Management” guideline and the study by Wiviott et al. (2019) in The Lancet also demonstrate high credibility and relevance, contributing valuable perspectives to different aspects of diabetes care. The choice of the most useful resource depends on specific parameters of the diagnosis and care context.

    The Importance of the Evidence-based Practice Model

    In managing chronic conditions like Type 2 diabetes, relying on reliable sources within an evidence-based practice (EBP) model is crucial. Credible evidence provides factual support for interventions and the development of reliable care plans. The Iowa model for Evidence-based Practice exemplifies this approach, guiding healthcare professionals in addressing the complexities of Type 2 diabetes through a structured and evidence-based methodology.

    Assessing the Credibility of Evidence and Resources

    Employing tools like the CRAAP criteria to identify credible and reliable information is essential for ensuring that the EBP model is founded on current, accurate, and relevant evidence. From the latest research on diabetes management to approved medications and lifestyle interventions, evidence guides changes within the organization and assesses the effectiveness of implemented changes. Trustworthy proof forms the foundation for every stage of the EBP process, influencing patient care decisions and enhancing the standard of care.

    Conclusion

    In conclusion, evidence-based practices play a crucial role in supporting clinical decisions and practices, particularly in managing complex health issues like Type 2 Diabetes. Models such as the Iowa model provide a structured approach, enhancing the ability of healthcare professionals to think critically and make decisions based on trustworthy and dependable resources. Implementing evidence-based approaches not only benefits the professional development of healthcare providers but also significantly improves the quality of patient-centered care, ultimately impacting healthcare outcomes and patient experiences positively.

    References

    Abu-Baker, N. N., AbuAlrub, S., Obeidat, R. F., & Assmairan, K. (2021). Evidence-based practice beliefs and implementations: A cross-sectional study among undergraduate nursing students. BMC Nursing, 20(1). https://doi.org/10.1186/s12912-020-00522-x

    American Diabetes Association. (2021). Standards of Medical Care in Diabetes: Abridged for Primary Care Providers. Clin. Diabetes, 39(1), 14–43. https://doi.org/10.2337/cd20-0104 2.

    NURS FPX 4030 Assessment 2 Determining the Credibility of Evidence and Resources

    Lowe, M. S., Macy, K. V., Murphy, E., & Kani, J. (2021). Questioning Craap. Journal of the Scholarship of Teaching and Learning, 21(3). https://doi.org/10.14434/josotl.v21i3.30744

    National Institute for Health and Care Excellence. (2021). Type 2 diabetes in adults: Management. https://www.nice.org.uk/guidance/ng28 3.

    Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., Ruff, C. T., Gause-Nilsson, I. A. M., Fredriksson, M., Johansson, P. A., Langkilde, A.M. (2019). Dapagliflozin and cardiovascular outcomes in type 2 diabetes. The New England Journal of Medicine, 380(4), 347–357. https://doi.org/10.1056/NEJMoa1812389

    NURS FPX 4030 Assessment 2 Determining the Credibility of Evidence and Resources

    World Health Organization. (2021). Global report on diabetes. https://www.who.int/publications/i/item/9789240013131 .